cu
cl
promot
synthesi
npropargylatedisatin
mannich
monoand
bisadduct
extens
toward
synthesi
conjug
describ
synthes
scaffold
evalu
vitro
activ
veterinari
protozo
pathogen
tritrichomona
foetu
cytotox
human
prostat
cancer
cell
line
preliminari
evalu
data
reveal
enhanc
activ
profil
introduct
ring
activ
conjug
exhibit
ic
mm
respect
foetu
minim
toxic
human
prostat
cell
line
bovin
trichomoniasi
vener
diseas
caus
protozo
pathogen
tritrichomona
foetu
consid
one
import
infecti
caus
reproduct
failur
beef
cattl
drastic
reduc
breed
effici
infect
bull
primarili
acquir
direct
sexual
contact
asymptomat
natur
affect
neither
semen
qualiti
sexual
behaviour
although
case
earli
death
develop
foetu
also
observ
literatur
rational
also
reveal
parasit
provok
cell
death
bovin
oviduct
epitheli
cell
extracellular
product
secret
foetu
cytotox
bovin
sperm
although
use
artifici
insemin
breed
cattl
led
virtual
erad
organ
cattl
popul
mani
countri
bovin
trichomonad
infect
still
respons
signific
econom
loss
freerang
cattl
industri
around
world
light
current
problem
identif
new
chemotherapi
pathogen
still
warrant
isatin
versatil
scaffold
wide
possibl
chemic
modif
display
divers
array
biolog
pharmacolog
activ
includ
antihiv
antivir
antitumour
antifung
antiangiogen
anticonvuls
antiparkinson
diseas
therapeut
effect
sar
coronaviru
proteas
inhibitor
extens
investig
synthet
versatil
isatin
disclos
mani
interest
aspect
organ
synthesi
allow
gener
larg
number
structur
divers
analogu
deriv
electrophil
aromat
substitut
posit
phenyl
ring
nucleophil
addit
onto
carbonyl
group
chemoselect
reduct
oxid
ringexpans
spiroannul
howev
report
regard
antineoplast
activ
nalkyl
naryl
isatin
vine
cowork
report
apoptosi
behaviour
nalkylaryl
isatin
introduct
variou
hydrophob
substitu
like
nphenethyl
nbenzyl
parent
nucleu
significantli
increas
cytotox
toward
lymphoma
cell
wide
rang
human
cancer
cell
line
includ
metastat
breast
adenocarcinoma
cell
human
monocytelik
histolyt
lymphoma
cell
recent
report
lab
shown
synthesi
nalkylisatin
along
cytotox
profil
panel
cancer
cell
line
approach
extend
toward
synthesi
isatin
conjug
four
synthes
scaffold
twice
potent
cell
line
continu
interest
toward
synthesi
novel
molecular
framework
biolog
relev
recent
disclos
synthesi
isatinblactam
conjug
along
preliminari
analysi
vitro
activ
trichomona
vaginali
mm
eighteen
synthes
hybrid
shown
growth
inhibit
mm
potent
noncytotox
compound
show
ic
mm
methodolog
extend
toward
synthesi
bamino
alcohol
base
blactameisatin
conjug
evalu
vaginali
mm
activ
chimer
scaffold
among
test
seri
exhibit
ic
mm
along
low
cytotox
extens
work
describ
cu
clfacilit
synthesi
npropargylatedisatin
mannich
adduct
along
preliminari
vitro
evalu
studi
veterinari
protozo
pathogen
foetu
cytotox
human
prostat
cancer
cell
line
synthet
approach
devis
synthesi
desir
hybrid
involv
sodium
hydrid
promot
initi
propagyl
substitut
isatin
propargyl
bromid
dri
dmf
yield
upon
reflux
c
dri
dioxan
secondari
amin
paraformaldehyd
presenc
catalyt
amount
cu
cl
result
isol
desir
npropargylatedisatin
mannich
adduct
mechanist
reaction
thought
proceed
initi
format
cuacetylid
undergo
mannich
addit
shown
scheme
interestingli
reaction
employ
piperazin
secondari
amin
unit
result
isol
bisadduct
form
via
initi
condens
reaction
piperazin
paraformaldehyd
posit
result
correspond
bisiminium
ion
subsequ
mannich
addit
develop
methodolog
extend
toward
synthesi
npropargyl
hybrid
via
cumedi
mannich
reaction
substitut
npropargyl
isatin
prepar
heat
excess
piperazin
triethylamin
c
overnight
scheme
inclus
chloroquinolin
nucleu
synthes
conjug
base
recent
disclosur
dwivedi
cowork
promis
activ
quinolin
base
compound
differ
strain
vaginali
structur
synthes
mannich
adduct
assign
basi
spectral
data
analyt
evid
compound
exampl
character
analys
c
synthes
compound
evalu
antitrichomona
activ
veterinari
protozo
pathogen
foetu
mm
result
provid
tabl
evid
tabl
antitrichomona
activ
test
compound
found
depend
upon
natur
substitu
posit
well
presenc
natur
secondari
amin
presenc
ech
substitu
posit
isatin
ring
synthes
mannich
adduct
consider
improv
activ
profil
evid
compound
introduct
moieti
remark
improv
antitrichomona
activ
prefer
halogen
substitu
posit
isatin
ring
potent
synthes
hybrid
show
growth
inhibit
mm
activ
compound
viz
preliminari
inhibit
data
chosen
order
determin
ic
minimum
concentr
requir
growth
inhibit
result
tabul
tabl
evid
tabl
although
synthes
conjug
activ
standard
drug
metronidazol
compound
show
potent
activ
veterinari
protozo
pathogen
foetu
compound
chlorosubstitu
posit
isatin
ring
prove
potent
synthes
scaffold
ic
mm
synthes
compound
evalu
cytotox
human
prostat
cancer
cell
line
order
confirm
observ
activ
profil
intrins
antitrichomona
activ
cytotox
cytotox
evalu
result
test
compound
mm
enlist
tabl
evid
virtual
synthes
mannich
adduct
devoid
cytotox
except
show
bisadduct
cytotox
cell
line
compar
monoadduct
potent
antitrichomona
scaffold
viz
show
cytotox
cell
line
consid
good
hit
conclus
present
manuscript
describ
cu
cl
promot
npropargylatedisatinmannich
monoa
well
bisadduct
extens
toward
synthesi
conjug
synthes
scaffold
evalu
activ
veterinari
protozo
pathogen
foetu
preliminari
evalu
data
reveal
introduct
ring
markedli
enhanc
activ
profil
activ
compound
exhibit
ic
mm
cytotox
studi
human
prostat
cell
line
show
synthes
mannich
adduct
virtual
devoid
cytotox
framework
act
ideal
start
point
synthesi
new
pharmacolog
templat
foetu
melt
point
determin
open
capillari
use
veego
precis
digit
melt
point
apparatu
mpd
uncorrect
h
nmr
spectra
record
deuterochloroform
dmsod
jeol
mhz
spectromet
use
tm
intern
standard
chemic
shift
valu
express
part
per
million
downfield
tm
j
valu
hertz
split
pattern
indic
singlet
doublet
triplet
multiplet
dd
doubl
doublet
ddd
doublet
doublet
doublet
br
broad
peak
c
nmr
spectra
record
jeol
mhz
spectromet
deuterochloroform
dmsod
use
tm
intern
standard
high
resolut
mass
spectra
record
brukermicrotofq
ii
spectromet
column
chromatographi
perform
silica
gel
mesh
procedur
synthesi
substitut
npropargyl
isatin
stir
suspens
sodium
hydrid
mmol
dri
dmf
ml
ad
isatin
mmol
result
format
purpl
colour
anion
solut
stir
room
temperatur
till
evolut
hydrogen
ceas
reaction
mixtur
ad
dropwis
solut
propargyl
bromid
mmol
dri
dmf
reaction
mixtur
heat
c
constant
stir
h
complet
reaction
evid
tlc
quench
dropwis
addit
water
ml
subsequ
extract
ethyl
acet
ml
combin
organ
layer
wash
brine
solut
dri
anhydr
na
concentr
reduc
pressur
purif
reaction
mixtur
via
column
chromatographi
use
hexan
ethyl
acet
mixtur
furnish
desir
npropargyl
isatin
deriv
good
yield
procedur
synthesi
well
stir
solut
mmol
triethylamin
mmol
piperazin
mmol
ad
reaction
mixtur
allow
stir
c
h
progress
reaction
mixtur
monitor
tlc
complet
wash
n
naoh
solut
subsequ
extract
ethi
lacet
ml
combin
organ
layer
wash
brine
solut
dri
anhydr
na
concentr
vacuum
result
desir
product
well
stir
solut
npropargyl
isatin
mmol
dri
dioxan
catalyt
amount
copper
chlorid
pformaldehyd
ad
success
reaction
mixtur
stir
min
subsequ
addit
secondari
amin
mmol
reflux
c
h
complet
reaction
evid
tlc
reaction
mixtur
filter
subsequ
extract
ethyl
acet
ml
combin
organ
layer
dri
anhydr
na
concentr
reduc
pressur
result
desir
mannich
adduct
good
yield
orang
solid
yield
mp
orang
solid
yield
mp
well
stir
solut
npropargyl
isatin
mmol
dri
dioxan
catalyt
amount
copper
chlorid
pformaldehyd
ad
success
reaction
mixtur
stir
min
subsequ
addit
piperazin
mmol
reflux
c
h
complet
reaction
evid
tlc
reaction
mixtur
filter
subsequ
extract
ethyl
acet
ml
combin
organ
layer
dri
anhydr
na
concentr
reduc
pressur
result
desir
bismannich
adduct
good
yield
bi
piperazin
orang
solid
yield
mp
typic
procedur
synthesi
mannich
adduct
mixtur
npropargyl
isatin
mmol
paraformaldehyd
mmol
mmol
anhydr
cupric
chlorid
mmol
dri
heat
c
h
complet
reaction
evidenc
tlc
reaction
mixtur
filter
filtrat
treat
brine
solut
extract
ethyl
acet
ml
combin
organ
layer
dri
na
solvent
evapor
reduc
pressur
result
crude
product
purifi
column
chromatographi
use
chloroform
methanol
mixtur
perform
initi
suscept
screen
foetu
strain
compound
dissolv
dmso
obtain
concentr
mm
ml
aliquot
suspens
dilut
ml
tym
diamond
media
obtain
final
concentr
mm
h
cell
count
use
hemacytomet
ic
valu
compound
determin
run
assay
increas
drug
concentr
mm
perform
regress
analysi
use
prism
softwar
graphpad
cell
cultur
dmem
supplement
fb
cell
plate
well
tissu
cultur
plate
treat
compound
concentr
rang
mm
h
ml
mtt
tetrazolium
bromid
mgml
pb
ad
well
plate
incub
h
plate
centrifug
rpm
min
supernat
remov
ml
dmso
ad
mix
shaker
min
absorb
measur
nm
envis
multilabel
plate
reader
perkin
elmer
percentag
inhibit
calcul
dose
respons
curv
plot
use
graph
pad
prism
grate
acknowledg
kl
would
like
acknowledg
pacif
fund
summer
undergradu
research
fellowship
univers
pacif
would
also
like
thank
dr
lydia
k
fox
director
undergradu
research
support
